ARCHIVES

DCT Board Approves Recompetition Of Clinical Trials, Other Contracts, New BNCT Grants

This article is from The Cancer Letter archive.

Vol. 14 No. 42 | October 28, 1988

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Close To Definition Of QRA

February 11, 1983

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007

Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director.

December 7, 2001

Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says

February 12, 1999

Symposium Addresses FCC issues

February 21, 1986

NCI Names Brawly Director of Office of Special Populations

June 21, 1996